1. Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma
   Lekshmi R. Nath et al, 2022, Current Cancer Drug Targets CrossRef
2. Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
   Aldona Kasprzak et al, 2019, International Journal of Molecular Sciences CrossRef
3. Advances in MUC1-Mediated Breast Cancer Immunotherapy
   Zhifeng Li et al, 2022, Biomolecules CrossRef
4. Radiation Resistance: A Matter of Transcription Factors
   Chiara Galeaz et al, 2021, Frontiers in Oncology CrossRef
5. MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
   Wenqing Chen et al, 2021, International Journal of Molecular Sciences CrossRef
6. Chimeric antigen receptor (CAR) T cell therapy in hepatocellular carcinoma; a review of recent advances
   Mohammad Amin Shahrbaf et al, 2021, Modern Medical Laboratory Journal CrossRef
7. Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
   Bo Lin et al, 2021, Frontiers in Oncology CrossRef
8. Role of Alpha-Fetoprotein in the Pathogenesis of Cancer
   Alok Ghosh Chaudhuri et al, 2024, Journal of Environmental Pathology, Toxicology and Oncology CrossRef
9. The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma
   Jang-Chun Lin et al, 2018, Cancers CrossRef
10. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
    Ping-Lian Yang et al, 2020, Cancers CrossRef